.webp)
Web Golinkin becomes CCO and president of Babson Diagnostics, aiming to advance affordable, patient-friendly blood testing with BetterWay.
Web Golinkin was appointed as chief commercial officer (CCO) and the president on 1 May 2025, to lead the company’s strategy for BetterWay blood testing by Babson Diagnostics, a healthcare technology company in Austin, Texas.
For the past 35 years, Golinkin was the CEO of five groundbreaking healthcare companies and also a co-founder of three. In America’s health network, FastMed and Health Dialogue Golinkin have played a great leadership role.
Golinkin said that being a part of Babson Diagnostics is a privilege and is eager to assist BetterWay. The company's advanced technology and strong dedication to patient-friendly diagnosis are revolutionary, and he’ll keep the promise of lowering healthcare expenses and improving patient care.
Chief Executive Officer of Babson Diagnostics, David Stein, stated that his involvement will be seen in improving the convenience of routine blood testing for all by expediting the organization's objective.
BetterWay is a patient-friendly blood testing service, accessible to all, and gives accurate and fast results. With Golinkin, Babson Diagnostics will have transformative growth.
.webp)
.webp)
